P1140: COMBINATION ANTI‐PD1 ANTIBODY AND RITUXIMAB FOLLOWED BY R‐CHOP FOR NEWLY DIAGNOSED DLBCL IN ELDERLY PATIENTS: ANALYSIS OF THE PHASE II TREND TRIAL.
- Resource Type
- Article
- Source
- HemaSphere; 2023 Supplement 3, Vol. 7, p1-2, 2p
- Subject
- Language
- ISSN
- 25729241